Health
Synthetic Mini-Antibody Identified to Combat COVID-19 – SciTechDaily
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to…
SARS-CoV-2’s ability to infect cells relies on interactions between the viral spike protein (magenta) and the protein ACE2 (blue), which is present on the surface of human cells. These interactions can be disrupted by sybodies (black) — synthetic mini-antibodies similar to those produced by camels and llamas. Credit: Rayne Zaayman-Gallant/EMBL
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus…
-
Business23 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News19 hours agoWilliam Robinson dies aged 89
-
Noosa News21 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats
-
Noosa News20 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89